J. A. Huntington, Serpin structure, function and dysfunction, J Thromb Haemost, vol.9, 2011.

M. Mcgrogan, J. Kennedy, P. Li, M. Hsu, C. Scott et al.,

, Molecular Cloning and Expression of Two Forms of Human Protease Nexin I, Nat Biotechnol, vol.6, pp.172-179, 1988.

M. C. Bouton, Y. Boulaftali, B. Richard, V. Arocas, J. B. Michel et al.,

, Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology, Blood, vol.119, pp.2452-2459, 2012.

Y. Boulaftali, L. Venisse, B. Richard, S. Taieb, D. Monard et al., Anticoagulant and antithrombotic properties of platelet protease nexin-1, Blood, vol.115, pp.97-106, 2010.

D. L. Evans, M. Mcgrogan, R. W. Scott, and R. W. Carrell, Protease specificity and heparin binding and activation of recombinant protease nexin I, J Biol Chem, vol.266, pp.22307-22319, 1991.

R. W. Scott, B. L. Bergman, A. Bajpai, R. T. Hersh, H. Rodriguez et al.,

S. Watts and J. B. Baker, Protease nexin. Properties and a modified purification procedure, J Biol Chem, vol.260, pp.7029-7063, 1985.

D. J. Knauer, D. Majumdar, P. C. Fong, and M. F. Knauer, SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor, J Biol Chem, vol.275, pp.37340-37346, 2000.

J. M. Hermans and S. R. Stone, Interaction of activated protein C with serpins, Biochem J, vol.295, pp.239-284, 1993.

L. Muhl, A. Nykjaer, M. Wygrecka, D. Monard, K. T. Preissner et al., Inhibition of PDGF-BB by Factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP, Biochem J, vol.404, pp.191-197, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00478689

Y. Boulaftali, B. Ho-tin-noe, A. Pena, S. Loyau, L. Venisse et al., Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis, Circulation, vol.123, pp.1326-1360, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00583943

K. Aymonnier, C. Kawecki, L. Venisse, Y. Boulaftali, and O. D. Christophe,

V. De-raucourt, E. Denis, C. V. Bouton, and M. , Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia, Blood, vol.134, pp.1632-1676, 2019.

K. J. Pasi, S. Rangarajan, P. Georgiev, T. Mant, M. D. Creagh et al.,

S. Austin, C. R. Hay, and I. Hegemann, Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy, N Engl J Med, vol.377, pp.819-847, 2017.

H. Eichler, P. Angchaisuksiri, K. Kavakli, P. Knoebl, J. Windyga et al.,

P. Harder-delff and P. Chowdary, Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data, Haemophilia, vol.25, pp.60-66, 2019.

S. Polderdijk, T. P. Baglin, and J. A. Huntington, Targeting activated protein C to treat hemophilia, Curr Opin Hematol, vol.24, pp.446-52, 2017.

S. Muyldermans, T. Atarhouch, J. Saldanha, J. A. Barbosa, and R. Hamers, Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains, Protein Eng, vol.7, pp.1129-1164, 1994.

S. Muyldermans, Single domain camel antibodies: current status, J Biotechnol, 2001.

D. Meyer, T. Muyldermans, S. Depicker, and A. , Nanobody-based products as research and diagnostic tools, Trends Biotechnol, vol.32, pp.263-70, 2014.

D. Smolarek, O. Bertrand, and M. Czerwinski, Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?, Postepy Hig Med Dosw (Online), 2012.

K. B. Vu, M. A. Ghahroudi, L. Wyns, and S. Muyldermans, Comparison of llama VH sequences from conventional and heavy chain antibodies, Mol Immunol, vol.34, pp.1121-1152, 1997.

S. Selbonne, F. Azibani, S. Iatmanen, Y. Boulaftali, B. Richard et al.,

M. Bouton and V. Arocas, In vitro and in vivo antiangiogenic properties of the serpin protease nexin-1, Mol Cell Biol, vol.32, pp.1496-505, 2012.

A. Bezeaud, M. H. Denninger, and M. C. Guillin, Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin, Eur J Biochem, vol.153, pp.491-497, 1985.

G. Aymé, F. Adam, P. Legendre, A. Bazaa, V. Proulle et al.,

P. J. Lenting, A Novel Single-Domain Antibody Against von Willebrand Factor A1 Domain Resolves Leukocyte Recruitment and Vascular Leakage During Inflammation

, Arterioscler Thromb Vasc Biol, vol.37, pp.1736-1776, 2017.

G. Behar, S. Sibéril, A. Groulet, P. Chames, M. Pugnière et al.,

J. Teillaud and D. Baty, Isolation and characterization of anti-FcgammaRIII (CD16) llama singledomain antibodies that activate natural killer cells, Protein Eng Des Sel, vol.21, pp.1-10, 2008.

E. Barbon, G. Ayme, A. Mohamadi, J. Ottavi, C. Kawecki et al.,

S. Marmier, L. Van-wittenberghe, and S. Charles, Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors, EMBO Mol Med, p.11298, 2020.
URL : https://hal.archives-ouvertes.fr/inserm-02551254

H. R. Hoogenboom, A. D. Griffiths, K. S. Johnson, D. J. Chiswell, P. Hudson et al., Multisubunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains, Nucleic Acids Res, vol.19, pp.4133-4140, 1991.

J. A. Irving, R. N. Pike, A. M. Lesk, and J. C. Whisstock, Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function, Genome Res, vol.10, pp.1845-64, 2000.

S. Moutel, N. Bery, V. Bernard, L. Keller, E. Lemesre et al.,

G. Favre and A. Olichon, NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies, vol.5, 2016.

C. J. Davidson, E. G. Tuddenham, and J. H. Mcvey, 450 million years of hemostasis, J Thromb Haemost, vol.1, pp.1487-94, 2003.

J. Sommer, S. M. Gloor, G. F. Rovelli, J. Hofsteenge, H. Nick et al., cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily, Biochemistry, vol.26, pp.6407-6417, 1987.